6/5
12:59 pm
vigl
These 2 ‘Strong Buy' Penny Stocks Are Poised for a Massive Rally, Say Analysts [Yahoo! Finance]
High
Report
These 2 ‘Strong Buy' Penny Stocks Are Poised for a Massive Rally, Say Analysts [Yahoo! Finance]
5/30
07:16 am
vigl
Vigil Neuroscience to Present in Upcoming June Investor Conferences [Yahoo! Finance]
Medium
Report
Vigil Neuroscience to Present in Upcoming June Investor Conferences [Yahoo! Finance]
5/30
07:05 am
vigl
Vigil Neuroscience to Present in Upcoming June Investor Conferences
Medium
Report
Vigil Neuroscience to Present in Upcoming June Investor Conferences
5/28
01:28 pm
vigl
All You Need to Know About Vigil Neuroscience (VIGL) Rating Upgrade to Buy [Yahoo! Finance]
Medium
Report
All You Need to Know About Vigil Neuroscience (VIGL) Rating Upgrade to Buy [Yahoo! Finance]
5/8
10:31 am
vigl
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $22.00 price target on the stock.
Medium
Report
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $22.00 price target on the stock.
5/8
09:19 am
vigl
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
High
Report
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
5/8
07:40 am
vigl
Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference
High
Report
Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference
5/7
04:19 pm
vigl
Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
5/7
04:05 pm
vigl
Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update
High
Report
Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update
4/18
02:12 pm
vigl
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $23.00 price target on the stock.
Medium
Report
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $23.00 price target on the stock.
4/17
04:19 pm
vigl
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting [Yahoo! Finance]
Medium
Report
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting [Yahoo! Finance]
4/17
04:05 pm
vigl
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
Medium
Report
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
3/27
10:08 am
vigl
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Medium
Report
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
3/26
07:14 am
vigl
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/26
07:05 am
vigl
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Medium
Report
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
3/24
09:53 am
vigl
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
Medium
Report
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
3/20
07:12 am
vigl
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer [Yahoo! Finance]
Medium
Report
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer [Yahoo! Finance]
3/20
07:05 am
vigl
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
Medium
Report
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer